GlassScriptPhysician profile
Jorge J Arango
NPI 1326081795
$4,653.28
in general payments reported to CMS, 2019-2025
19 companies · $702 in 2025
The $702 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $93.92 · 2021: $553 · 2022: $540 · 2023: $239 · 2024: $2,295 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,535 · Travel and Lodging: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,535.33 |
| Travel and Lodging | $701.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,006.41 | 2023-2025 | |
| Genzyme Corporation | $553.89 | 2024-2025 | |
| Intersect Ent, INC. | $390.68 | 2019-2022 | |
| Glaxosmithkline, LLC. | $353.63 | 2021-2025 | Nucala |
| Stryker Corporation | $232.07 | 2021-2025 | Scopis Ent |
| Intuitive Surgical, INC. | $176.11 | 2022 | |
| Optinose US, INC. | $141.62 | 2020-2021 | |
| Inspire Medical Systems, INC. | $134.69 | 2021-2025 | Inspire |
| Acclarent, INC | $118.50 | 2021 | |
| Smith+Nephew, INC. | $103.50 | 2022 | |
| Medtronic, INC. | $96.07 | 2025 | Propel |
| Agiliti Surgical, INC. | $92.61 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $89.32 | 2021-2024 | Dupixent |
| Abbott Laboratories | $45.91 | 2024 | Eterna |
| Novartis Pharmaceuticals Corporation | $31.31 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $28.92 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.04 | 2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $18.25 | 2025 | Xhance |
| Integra Lifesciences Corporation | $15.75 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Arango listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.